Next Article in Journal
Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
Next Article in Special Issue
Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta Variant
Previous Article in Journal
Rapid Implementation of a Community–Academic Partnership Model to Promote COVID-19 Vaccine Equity within Racially and Ethnically Minoritized Communities
Previous Article in Special Issue
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
 
 
Article

Article Versions Notes

Vaccines 2022, 10(8), 1365; https://doi.org/10.3390/vaccines10081365
Action Date Notes Link
article xml file uploaded 21 August 2022 10:06 CEST Original file -
article xml uploaded. 21 August 2022 10:06 CEST Update https://www.mdpi.com/2076-393X/10/8/1365/xml
article pdf uploaded. 21 August 2022 10:06 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1365/pdf
article supplementary file uploaded. 21 August 2022 10:06 CEST - https://www.mdpi.com/2076-393X/10/8/1365#supplementary
article html file updated 21 August 2022 10:07 CEST Original file -
article html file updated 24 August 2022 21:10 CEST Update https://www.mdpi.com/2076-393X/10/8/1365/html
Back to TopTop